Medical - Care Facilities
Compare Stocks
2 / 10Stock Comparison
HCSG vs AMSF
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Specialty
HCSG vs AMSF — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Care Facilities | Insurance - Specialty |
| Market Cap | $1.58B | $556M |
| Revenue (TTM) | $1.84B | $325M |
| Net Income (TTM) | $59M | $46M |
| Gross Margin | 13.3% | 47.6% |
| Operating Margin | 3.0% | 17.8% |
| Forward P/E | 20.6x | 14.1x |
| Total Debt | $25M | $491K |
| Cash & Equiv. | $161M | $62M |
HCSG vs AMSF — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Healthcare Services… (HCSG) | 100 | 92.3 | -7.7% |
| AMERISAFE, Inc. (AMSF) | 100 | 48.2 | -51.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HCSG vs AMSF
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HCSG is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 20 yrs, beta 1.12
- Rev growth 7.1%, EPS growth 52.8%, 3Y rev CAGR 2.8%
- 7.1% revenue growth vs AMSF's 2.6%
AMSF carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 33.4% 10Y total return vs HCSG's -27.0%
- Lower volatility, beta 0.23, Low D/E 0.2%, current ratio 0.32x
- Beta 0.23, yield 8.6%, current ratio 0.32x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.1% revenue growth vs AMSF's 2.6% | |
| Value | Lower P/E (14.1x vs 20.6x) | |
| Quality / Margins | 14.3% margin vs HCSG's 3.2% | |
| Stability / Safety | Beta 0.23 vs HCSG's 1.12, lower leverage | |
| Dividends | 8.6% yield; the other pay no meaningful dividend | |
| Momentum (1Y) | +53.4% vs AMSF's -31.7% | |
| Efficiency (ROA) | 7.3% ROA vs AMSF's 5.6%, ROIC 9.0% vs 21.9% |
HCSG vs AMSF — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
HCSG vs AMSF — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
AMSF leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HCSG is the larger business by revenue, generating $1.8B annually — 5.7x AMSF's $325M. AMSF is the more profitable business, keeping 14.3% of every revenue dollar as net income compared to HCSG's 3.2%. On growth, AMSF holds the edge at +10.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.8B | $325M |
| EBITDAEarnings before interest/tax | $72M | $58M |
| Net IncomeAfter-tax profit | $59M | $46M |
| Free Cash FlowCash after capex | $139M | $8M |
| Gross MarginGross profit ÷ Revenue | +13.3% | +47.6% |
| Operating MarginEBIT ÷ Revenue | +3.0% | +17.8% |
| Net MarginNet income ÷ Revenue | +3.2% | +14.3% |
| FCF MarginFCF ÷ Revenue | +7.6% | +2.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.6% | +10.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +175.0% | -8.5% |
Valuation Metrics
AMSF leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 12.0x trailing earnings, AMSF trades at a 56% valuation discount to HCSG's 27.2x P/E. On an enterprise value basis, AMSF's 8.3x EV/EBITDA is more attractive than HCSG's 22.1x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.6B | $556M |
| Enterprise ValueMkt cap + debt − cash | $1.4B | $495M |
| Trailing P/EPrice ÷ TTM EPS | 27.25x | 11.98x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.61x | 14.09x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 22.12x | 8.30x |
| Price / SalesMarket cap ÷ Revenue | 0.86x | 1.75x |
| Price / BookPrice ÷ Book value/share | 3.16x | 2.25x |
| Price / FCFMarket cap ÷ FCF | 11.36x | 62.35x |
Profitability & Efficiency
AMSF leads this category, winning 4 of 7 comparable metrics.
Profitability & Efficiency
HCSG delivers a 11.8% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $10 for AMSF. AMSF carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to HCSG's 0.05x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +11.8% | +9.7% |
| ROA (TTM)Return on assets | +7.3% | +5.6% |
| ROICReturn on invested capital | +9.0% | +21.9% |
| ROCEReturn on capital employed | +7.7% | +16.8% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.05x | 0.00x |
| Net DebtTotal debt minus cash | -$136M | -$61M |
| Cash & Equiv.Liquid assets | $161M | $62M |
| Total DebtShort + long-term debt | $25M | $491,000 |
| Interest CoverageEBIT ÷ Interest expense | 33.02x | — |
Total Returns (Dividends Reinvested)
HCSG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AMSF five years ago would be worth $7,946 today (with dividends reinvested), compared to $7,863 for HCSG. Over the past 12 months, HCSG leads with a +53.4% total return vs AMSF's -31.7%. The 3-year compound annual growth rate (CAGR) favors HCSG at 13.7% vs AMSF's -9.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +27.2% | -20.1% |
| 1-Year ReturnPast 12 months | +53.4% | -31.7% |
| 3-Year ReturnCumulative with dividends | +47.0% | -26.1% |
| 5-Year ReturnCumulative with dividends | -21.4% | -20.5% |
| 10-Year ReturnCumulative with dividends | -27.0% | +33.4% |
| CAGR (3Y)Annualised 3-year return | +13.7% | -9.6% |
Risk & Volatility
Evenly matched — HCSG and AMSF each lead in 1 of 2 comparable metrics.
Risk & Volatility
AMSF is the less volatile stock with a 0.23 beta — it tends to amplify market swings less than HCSG's 1.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HCSG currently trades 90.5% from its 52-week high vs AMSF's 61.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.12x | 0.23x |
| 52-Week HighHighest price in past year | $24.39 | $48.54 |
| 52-Week LowLowest price in past year | $12.66 | $29.42 |
| % of 52W HighCurrent price vs 52-week peak | +90.5% | +61.0% |
| RSI (14)Momentum oscillator 0–100 | 59.7 | 34.8 |
| Avg Volume (50D)Average daily shares traded | 676K | 211K |
Analyst Outlook
HCSG leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates HCSG as "Hold" and AMSF as "Buy". Consensus price targets imply 50.3% upside for AMSF (target: $45) vs 11.0% for HCSG (target: $25). AMSF is the only dividend payer here at 8.61% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $24.50 | $44.50 |
| # AnalystsCovering analysts | 15 | 6 |
| Dividend YieldAnnual dividend ÷ price | — | +8.6% |
| Dividend StreakConsecutive years of raises | 20 | 0 |
| Dividend / ShareAnnual DPS | — | $2.55 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.9% | +2.2% |
AMSF leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). HCSG leads in 2 (Total Returns, Analyst Outlook). 1 tied.
HCSG vs AMSF: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is HCSG or AMSF a better buy right now?
For growth investors, Healthcare Services Group, Inc.
(HCSG) is the stronger pick with 7. 1% revenue growth year-over-year, versus 2. 6% for AMERISAFE, Inc. (AMSF). AMERISAFE, Inc. (AMSF) offers the better valuation at 12. 0x trailing P/E (14. 1x forward), making it the more compelling value choice. Analysts rate AMERISAFE, Inc. (AMSF) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HCSG or AMSF?
On trailing P/E, AMERISAFE, Inc.
(AMSF) is the cheapest at 12. 0x versus Healthcare Services Group, Inc. at 27. 2x. On forward P/E, AMERISAFE, Inc. is actually cheaper at 14. 1x.
03Which is the better long-term investment — HCSG or AMSF?
Over the past 5 years, AMERISAFE, Inc.
(AMSF) delivered a total return of -20. 5%, compared to -21. 4% for Healthcare Services Group, Inc. (HCSG). Over 10 years, the gap is even starker: AMSF returned +33. 4% versus HCSG's -27. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HCSG or AMSF?
By beta (market sensitivity over 5 years), AMERISAFE, Inc.
(AMSF) is the lower-risk stock at 0. 23β versus Healthcare Services Group, Inc. 's 1. 12β — meaning HCSG is approximately 386% more volatile than AMSF relative to the S&P 500. On balance sheet safety, AMERISAFE, Inc. (AMSF) carries a lower debt/equity ratio of 0% versus 5% for Healthcare Services Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — HCSG or AMSF?
By revenue growth (latest reported year), Healthcare Services Group, Inc.
(HCSG) is pulling ahead at 7. 1% versus 2. 6% for AMERISAFE, Inc. (AMSF). On earnings-per-share growth, the picture is similar: Healthcare Services Group, Inc. grew EPS 52. 8% year-over-year, compared to -14. 5% for AMERISAFE, Inc.. Over a 3-year CAGR, HCSG leads at 2. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HCSG or AMSF?
AMERISAFE, Inc.
(AMSF) is the more profitable company, earning 14. 9% net margin versus 3. 2% for Healthcare Services Group, Inc. — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMSF leads at 18. 6% versus 2. 6% for HCSG. At the gross margin level — before operating expenses — AMSF leads at 46. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HCSG or AMSF more undervalued right now?
On forward earnings alone, AMERISAFE, Inc.
(AMSF) trades at 14. 1x forward P/E versus 20. 6x for Healthcare Services Group, Inc. — 6. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMSF: 50. 3% to $44. 50.
08Which pays a better dividend — HCSG or AMSF?
In this comparison, AMSF (8.
6% yield) pays a dividend. HCSG does not pay a meaningful dividend and should not be held primarily for income.
09Is HCSG or AMSF better for a retirement portfolio?
For long-horizon retirement investors, AMERISAFE, Inc.
(AMSF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 23), 8. 6% yield). Both have compounded well over 10 years (AMSF: +33. 4%, HCSG: -27. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HCSG and AMSF?
These companies operate in different sectors (HCSG (Healthcare) and AMSF (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: HCSG is a small-cap quality compounder stock; AMSF is a small-cap deep-value stock. AMSF pays a dividend while HCSG does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.